GX-03 + Petrolatum ointment
Phase 2Completed 0 watching 0 views this week⚡ Active
44
Development Stage
✓
Pre-clinical✓
Phase 13
Phase 24
Phase 35
ApprovedIndication / Disease
Covid19
Conditions
Covid19
Trial Timeline
Jan 21, 2021 → May 30, 2021
NCT ID
NCT04951349About GX-03 + Petrolatum ointment
GX-03 + Petrolatum ointment is a phase 2 stage product being developed by Turn Therapeutics for Covid19. The current trial status is completed. This product is registered under clinical trial identifier NCT04951349. Target conditions include Covid19.
Hype Score Breakdown
Clinical
17
Activity
12
Company
2
Novelty
5
Community
5
Clinical Trials (1)
| NCT ID | Phase | Status |
|---|---|---|
| NCT04951349 | Phase 2 | Completed |
Competing Products
20 competing products in Covid19